Value-based kidney care company Strive Health announced it signed a multiyear deal with Oak Street Health, a chain of primary care clinics geared toward the Medicare population to provide care to patients suffering from stage 4 chronic kidney disease to end-stage kidney disease.
Denver-based Strive Health offers a value-based care platform that integrates chronic kidney disease and end-stage...
Digital chronic disease management platform Health2Sync has signed a memorandum of understanding with pharmaceutical firm AstraZeneca to launch a digital patient management programme for patients with chronic kidney disease.
The digital programme seeks to promote the early diagnosis of CKD and optimise everyday CKD care using Health2Sync's patient management platform.
According to a media release...
Smartphone urinalysis and wound-care company Healthy.io received FDA 510(k) clearance for home use of its Minuteful kidney-damage test.
The test is used to determine the increased presence of a protein called albumin in the urine, which can be an early sign of chronic kidney disease. The kit includes a testing strip, a sample cup and color board. Patients dip the test strip into their urine...
Researchers from the Singapore Eye Research Institute have developed two novel AI-powered tools for screening chronic kidney disease and predicting a person's biological age from retina photos.
Both tools use AI deep learning algorithms to scan photos of an individual's retina to assess their health condition.
WHAT THEY DO
The kidney disease screening tool called RetiKid was developed by SERI and...
A Tel Aviv-based healthtech company has been brought in as a strategic partner by Dubai’s Seed Group, it has been announced.
As a result of this new partnership, Healthy.io – known for its capabilities to transform a smartphone into a medical device – will expand its operations in the GCC and wider region by setting up a base in Dubai in the first instance. The company, founded in 2013, currently...
Dialysis care solutions developer Baxter Asia Pacific has rolled out an online resource portal to support patients living with chronic kidney disease in Indonesia.
The My Kidney Journey website hosts information on CKD, such as symptoms, causes, and stages, as well as the latest information on multiple treatment options to manage the disease, including Peritoneal Dialysis at home, in-centre...
Chronic kidney disease and end-stage renal disease management company Monogram Health has closed a $160 million Series B funding round led by TPG Capital.
Existing investors Frist Cressey Ventures, Norwest Venture Partners and Humana Inc. also participated in the raise.
Along with their investment, TPG Capital co-managing partner Todd Sisitsky is joining Monogram’s board of directors.
WHAT IT...
Clinical diagnostic company Renalytix AI has expanded its partnership with the Joslin Diabetes Center to integrate new biomarkers for kidney disease discovered by the center's researchers into the company’s KidneyIntelX platform.
KidneyIntelX is an in vitro diagnostic platform that assesses the risk of adverse kidney outcomes in patients with Type 2 diabetes and early-stage kidney disease. By...
Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases.
The first stage of the collaboration will use KidneyIntelX, an AI-enabled in vitro diagnostic platform that gathers patient data from electronic medical records to generate a...
New England-based health plan Harvard Pilgrim Health Care announced plans to pilot a medication adherence study that makes use of MedMinder Systems' wireless-enabled pillbox. The randomized controlled study, which is set to begin in early September, aims to determine how effective MedMinder's system is on a population of patients with chronic kidney disease (CKD). CKD affects 26 million...
![[Left] Ed Deng, co-founder and CEO, Health2Sync; and [Right] Claudio Longo, President, AstraZeneca Taiwan](https://www.mobihealthnews.com/sites/default/files/styles/230x130/public/%28Left%29%20Ed%20Deng%2C%20Co-founder%20and%20CEO%20of%20Health2Sync%20and%20%28Right%29%20Claudio%20Longo%2C%20President%20of%20AstraZeneca%20Taiwan.jpg?itok=O1YqUgdy)
